ebola
continu
make
wave
gener
specialist
journal
highprofil
public
includ
clinic
detail
larg
cohort
case
sierra
leon
confirm
case
fatal
rate
controversi
quarantin
person
protect
equip
whether
scale
prepared
develop
healthcar
system
match
risk
laboratori
safeti
social
humanitarian
impact
west
africa
epidemiolog
includ
stark
world
health
organ
project
thousand
new
case
per
week
west
africa
transmiss
dynam
promis
vaccin
trial
antibiot
use
abus
european
antibiot
awar
day
roughli
correspond
us
get
smart
antibiot
week
impress
coordin
strategi
difficult
find
right
metric
measur
success
evid
europ
public
understand
antibiot
gradual
improv
recent
world
health
assembl
resolut
antimicrobi
resist
help
jama
recent
publish
special
issu
infecti
diseas
number
antibioticrel
articl
impress
cluster
random
control
trial
compar
impact
select
oral
decontamin
select
digest
decontamin
sdd
multicentr
dutch
intens
care
unit
icu
studi
sdd
associ
lower
level
gastrointestin
carriag
antibioticresist
gramneg
bacteria
icuacquir
bacteraemia
pronounc
increas
aminoglycosideresist
gramneg
bacteria
afford
give
antibiot
indiscrimin
highrisk
group
multist
collect
point
preval
survey
antibiot
use
usa
publish
jama
found
almost
exactli
patient
antibiot
rate
consider
higher
rate
found
point
preval
survey
europ
furthermor
least
patient
us
survey
antibiot
good
reason
meanwhil
commentari
new
england
journal
medicin
discuss
problem
progress
prospect
antibiot
resist
articl
outlin
need
recognit
problem
incentiv
develop
new
agent
move
cure
toward
prevent
leadership
stewardship
howev
articl
journal
antimicrobi
chemotherapi
highlight
stark
realiti
antibiot
problem
part
world
approxim
onethird
commun
prescrib
spain
admit
dispens
antibiot
without
prescript
like
real
figur
consider
greater
recent
articl
contribut
ongo
debat
whether
univers
target
approach
infect
prevent
adopt
implement
antimicrobi
surfac
promis
univers
approach
recent
studi
publish
american
journal
infect
control
found
quaternari
ammonium
organosilan
product
reduc
averag
bacteri
count
icu
surfac
approxim
eight
week
applic
howev
chitosanimpregn
scrub
fare
well
signific
reduct
bacteri
contamin
compar
untreat
control
one
commonli
cite
reason
move
away
contact
precaut
patient
infect
colon
meticillinresist
staphylococcu
aureu
mrsa
vancomycinresist
enterococci
vre
patient
contact
precaut
increas
rate
advers
event
howev
studi
publish
journal
hospit
infect
found
abandon
contact
precaut
patient
mrsa
vre
affect
rate
advers
event
may
suggest
increas
rate
advers
event
patient
contact
precaut
underli
risk
factor
contact
precaut
per
se
threat
multidrugresist
gramneg
bacteria
continu
unfold
encourag
see
success
stori
report
itali
region
intervent
revers
trend
carbapenemresist
klebsiella
pneumonia
howev
disturb
studi
also
itali
report
high
rate
colistin
resist
carbapenemresist
k
pneumonia
across
countri
fortun
isol
pandrug
resist
trend
concern
final
outbreak
new
delhi
enterobacteriacea
associ
contamin
duodenoscop
highlight
need
appropri
decontamin
perhap
even
steril
duodenoscop
confer
id
week
took
place
philadelphia
usa
earli
octob
confer
theme
includ
global
outbreak
threat
ebola
middl
east
respiratori
syndrom
mer
import
improv
surveil
healthcareassoci
communityassoci
infect
includ
need
embrac
new
technolog
updat
clostridium
difficil
treatment
epidemiolog
strong
focu
impress
impact
faecal
microbiota
transplant
improv
clean
disinfect
use
educ
train
supplement
use
autom
room
decontamin
technolog
futur
issu
infect
prevent
control
princip
move
away
contact
precaut
mrsa
vre
urgent
need
antibiot
stewardship
biannual
healthcar
infect
societi
confer
took
place
lyon
franc
mid
novemb
confer
trend
includ
updat
c
difficil
noroviru
pathogen
associ
healthcareassoci
infect
coverag
option
deal
contamin
healthcar
environ
need
educ
commun
turn
rise
tide
antibiot
resist
special
edit
journal
hospit
infect
dedic
confer
publish
deal
contamin
surfac
challeng
studi
italian
belgian
research
propos
novel
solut
deliber
seed
hospit
surfac
bacillu
spp
spore
reduc
ecolog
space
contamin
pathogen
remain
seen
whether
catch
